相关实验视频
Updated: Jan 10, 2026

21:08
Engineering Cell-permeable Protein
Published on: December 28, 2009
14.9K
工程调节的亲和蛋白质,用于有效的内化和溶酶体毒素输送
Malin Jönsson1, Marit Möller1, Leon Schierholz2
1Department of Protein Science, SciLifeLab, KTH-Royal Institute of Technology, Stockholm, Sweden.
概括
研究人员开发了一种新的调节蛋白质结合剂,用于向癌症治疗. 这种工程蛋白向癌细胞,将毒素传递给溶酶体,用于强烈的细胞杀死,增强药物传递效率.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症治疗 癌症治疗
背景情况:
- 蛋白-药物合物 (PDCs) 通过向瘤细胞传递细胞毒性有效载荷,提供向癌症治疗.
- 有效的PDC疗法依赖于有效载荷的内部化和目标细胞内的保留.
- 目前的战略面临的挑战是控制有效载荷释放和受体回收.
研究的目的:
- 为了设计一种具有调节 afinity 的蛋白质域,用于控制目标结合和 lysosomal 贩运.
- 开发一种用于向癌症治疗的新型药物输送系统.
- 评估调节结合剂在向癌细胞输送毒素方面的有效性.
主要方法:
- 一种表皮生长因子受体 (EGFR) 结合剂的工程,具有调节的亲和力 (CaRA).
- afinity测量和结构建模,以了解调节的结合.
- 活细胞成像用于追踪内部化,溶酶体贩运和受体命运.
- 细胞毒性测试以确定毒素输送系统的有效性.
主要成果:
- 该CaRA_EGFR结合剂表现出依赖的亲和力,促进内体解离.
- 活细胞成像证实了结合剂的高效内化和溶酶体贩运,通过EGFR回收利用.
- 在表达EGFR的癌细胞中,CaRA_EGFR有效地将毒素传递到 lysosomes,从而达到强大的细胞毒性 (IC50 = 0.8 nM).
结论:
- 工程调节的蛋白质域可以实现有针对性的有效载荷传递和独立于受体命运的溶酶体贩运.
- 这种方法提供了一种新的策略,用于增强癌症治疗中蛋白质药物合物的疗效.
- CaRA_EGFR代表了开发下一代向癌症治疗的有希望的工具.
相关概念视频
Lysosomes
25.2K
Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
25.2K
Receptor-mediated Endocytosis
110.4K
Overview
110.4K
Receptor-mediated Endocytosis
7.5K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.5K
Delivery Pathways to the Lysosome
8.7K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Clathrin Coated Vesicles
9.0K
Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...
9.0K

